Novamed, Sanofi say concerns raised in Brazil CADE market test are mitigated
Novamed and Sanofi have responded to concerns raised by customers and competitors in a market test conducted by Brazil’s competition authority for its review of Novamed’s planned acquisition of Medley, Sanofi’s...To view the full article, register now.
Already a subscriber? Click here to view full article